...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of paediatrics and child health >Review of the management of childhood asthma in Tasmania
【24h】

Review of the management of childhood asthma in Tasmania

机译：塔斯马尼亚州儿童哮喘的治疗回顾

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aim To review the supply of medications to children with asthma and parent-reported management of childhood asthma in Tasmania and highlight evidence-practice gaps for future interventions. Methods Participating pharmacies ran a software application that extracted data from dispensing records and helped to identify children with asthma. Parents of identified children were mailed a survey evaluating components of asthma management. Dispensing and survey data were analysed. Results A total of 939 children from 23 pharmacies were identified by the software and deemed eligible for inclusion. Surveys were received from 353 (37.6%) parents. In the past year, short-acting beta-2 agonists were supplied to 56.1% of the cohort, preventers to 76.5% (inhaled corticosteroids 52.3%; leukotriene receptor antagonists 31.3%; inhaled cromones 0.6%), long-acting beta-2 agonists (LABAs) to 25.7% and oral corticosteroids to 21.5%. Approximately half of the children receiving inhaled corticosteroids were concurrently receiving a LABA. Among children with indicators of inadequately controlled asthma, up to 73.7% of their parents reported that their asthma was adequately controlled, up to 38.2% did not possess an Asthma Action Plan, up to 36.8% were not regularly using a spacer and up to 22.8% had not received a preventer. Conclusion These results indicate gaps in childhood asthma management, in particular, undersupply of preventers in high-risk patient groups, high supply of LABAs and insufficient spacer and asthma action plan usage. These areas should be targeted for interventions to improve childhood asthma management.
机译：目的回顾塔斯马尼亚州哮喘儿童的药物供应和父母报告的儿童哮喘的管理，并强调证据和实践之间的差距，以备将来干预。方法参与活动的药店运行了一个软件应用程序，该软件从配药记录中提取数据并帮助识别儿童哮喘。已将已识别儿童的父母邮寄了一份调查，评估哮喘管理的组成部分。分配和调查数据进行了分析。结果通过该软件识别了来自23个药房的939名儿童，并认为他们符合纳入条件。从353位（37.6％）父母那里接受了调查。在过去的一年中，向该队列的56.1％提供了短效β-2激动剂，为76.5％提供了预防剂（吸入皮质类固醇为52.3％;白三烯受体拮抗剂为31.3％;吸入cromones为0.6％），长效β-2激动剂。 （LABAs）为25.7％，口服皮质类固醇为21.5％。大约一半接受吸入糖皮质激素治疗的儿童同时接受LABA治疗。在哮喘控制指标不足的儿童中，多达73.7％的父母报告说他们的哮喘得到了有效控制，高达38.2％的人没有哮喘行动计划，高达36.8％的人没有定期使用间隔物，高达22.8％ ％未收到预防剂。结论这些结果表明儿童哮喘管理方面存在差距，特别是高风险患者组的预防药供应不足，LABA的供应过多以及间隔子和哮喘行动计划的使用不足。这些区域应针对改善儿童哮喘管理的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号